Case report: Inflammatory bowel disease triggered by secukinumab in a female case of axial spondyloarthritis accompanied with symptomatic epilepsy

Int J Rheum Dis. 2024 May;27(5):e15194. doi: 10.1111/1756-185X.15194.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Anticonvulsants / adverse effects
  • Anticonvulsants / therapeutic use
  • Axial Spondyloarthritis* / diagnosis
  • Axial Spondyloarthritis* / drug therapy
  • Epilepsy* / diagnosis
  • Epilepsy* / drug therapy
  • Female
  • Humans
  • Inflammatory Bowel Diseases / complications
  • Inflammatory Bowel Diseases / diagnosis
  • Inflammatory Bowel Diseases / drug therapy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Anticonvulsants
  • secukinumab